BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹946 Cr | ₹817 Cr | ₹811 Cr | ₹697 Cr | ₹777 Cr |
What is the latest Total Current Assets ratio of BLISS GVS PHARMA ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹946 Cr |
| Mar2025 | ₹817 Cr |
| Mar2024 | ₹811 Cr |
| Mar2023 | ₹697 Cr |
| Mar2022 | ₹777 Cr |
How is Total Current Assets of BLISS GVS PHARMA Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹946 Cr | 15.88 | |
| Mar2025 | ₹817 Cr | 0.71 | |
| Mar2024 | ₹811 Cr | 16.28 | |
| Mar2023 | ₹697 Cr | -10.23 | |
| Mar2022 | ₹777 Cr | - | |
Compare Total Current Assets of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹7,679.6 Cr | 3.7% | 40.9% | 356.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 3.7% |
40.9% |
356.5% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses